VisualMed Clinical Solutions, Corp. provides update from new CEO
Company, Genome, Health care, PALM, Pain, U.S. Securities and Exchange Commission, Report, COVID-19, Gaps, GLOBE, Acquisition, SEC, Security (finance), Diabetes, Physician, Efficiency, Private Securities Litigation Reform Act, Health, Chief information officer, Marketing, Time, Automation, CIO, Hospital, Risk, Lists of diseases, Pharmacotherapy, Federal Neuro Psychiatric Hospital, Yaba, Safety, OTC, Laboratory information management system, Patient, Compliance, Solution, Sierra Nevada Corporation, Organization, CEO, OTC Markets Group, Workflow, Cardiovascular disease, Mission statement, Technology, Corporate title, Risk management, Management, Online shopping, Pharmaceutical industry, Sales, Healthcare, Medical device
WEST PALM BEACH, Fla., Aug. 30, 2021 (GLOBE NEWSWIRE) -- VisualMed Clinical Solutions, Corp. (A Nevada Corporation) (OTC: VMCS), provides an update from its new CEO
Key Points:
- WEST PALM BEACH, Fla., Aug. 30, 2021 (GLOBE NEWSWIRE) -- VisualMed Clinical Solutions, Corp. (A Nevada Corporation) (OTC: VMCS), provides an update from its new CEO
I look forward to the opportunity and challenge created as a result of becoming part of VisualMed though the recent acquisition from Rennova Health. - VisualMed is a long-standing public company with a significant and long-established shareholder base that I believe will benefit from the renewed business strategy resulting from this acquisition.
- We have several software solutions that are fully developed and tested that we are ready to market.
- These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.